Results 81 to 90 of about 17,216 (258)

A simulation study to compare median survival time estimators for interval-censoring

open access: yesSongklanakarin Journal of Science and Technology (SJST)
The objective of this study is to compare nonparametric methods for estimating the median survival time from intervalcensored data, under varying levels of right-censoring (30%, 40%, and 50%) and sample sizes (80, 200, and 400), using Monte Carlo ...
Prapasiri Ratchaprapapornkul   +1 more
doaj  

The Kaplan Meier Estimate in Survival Analysis [PDF]

open access: yesBiometrics & Biostatistics International Journal, 2017
Kaplan-Meier is a statistical method used in the analysis of time to event data. Time to event means the time from entry into a study until a particular event, for example onset of illness. This method is very useful in survival analysis as it is used by the researchers to determine and/or analyze the patients or participants who lost to follow up or ...
openaire   +1 more source

Disease Course After Anti‐CD20 Discontinuation in Secondary Progressive Multiple Sclerosis—A Multicenter Long‐Term Longitudinal Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto   +12 more
wiley   +1 more source

“Low‐Positive” MOG‐IgG Cases Among Adults With a First Event Suggestive of Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine the prevalence and clinical characteristics of patients with “low‐positive” (LP) MOG‐IgG (titres 1:160–1:320) among adults with a first demyelinating event (FDE) suggestive of multiple sclerosis (MS). Methods From the Barcelona CIS inception cohort, we included adult patients with serum collected ≤ 6 months from the FDE.
Javier Villacieros‐Álvarez   +29 more
wiley   +1 more source

Anti‐CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non‐Active Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine whether discontinuing anti‐CD20 therapy in people with relapsing‐onset MS aged over 50 is associated with an increased risk of relapse, inflammatory activity, confirmed disability accrual, and serious infection compared with continuing therapy.
Alexia Moukhine   +40 more
wiley   +1 more source

COMPARISON OF CONFIDENCE INTERVALS FOR THE SURVIVAL FUNCTION IN THE PRESENCE OF RIGHT CENSORING COMPARACIÓN DE INTERVALOS DE CONFIANZA PARA LA FUNCIÓN DE SUPERVIVENCIA CON CENSURA A DERECHA

open access: yesRevista Colombiana de Estadística, 2011
This work compares methods to find confidence interval for the survival function such as the resampling methods Bootstrap, applied to the Kaplan-Meier and Nelson-Aalen estimators.
Ramírez Javier
doaj  

Safety and Efficacy of GLP‐1 Receptor Agonists in Adults With Epilepsy, Obesity, and Type 2 Diabetes

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Managing obesity in patients with epilepsy is complicated by the weight‐gaining properties of essential antiseizure medications (ASMs) such as valproate and pregabalin. We evaluated the safety and efficacy of initiating glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) in this population.
Hyoshin Son   +3 more
wiley   +1 more source

Survival Analysis of Patients with Lung Cancer Using Cox Regression Model

open access: yesJournal of Mazandaran University of Medical Sciences, 2018
Background and purpose: Lung cancer is the third cause of death and amongst the five common cancers in Iran. The aim of this study was to analyze the survival rate of patients with lung cancer and identifying the variables influencing their survival ...
Fatemeh Babanejhad   +5 more
doaj  

Inebilizumab in AQP4‐Seropositive NMOSD: One‐Year Follow‐Up From a Multicenter, Real‐World Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Real‐world evidence on inebilizumab among neuromyelitis optica spectrum disorder (NMOSD) patients is lacking. This study assessed inebilizumab among Chinese patients with aquaporin 4 autoantibody (AQP4‐IgG)‐seropositive NMOSD in a real‐world setting.
Mengcui Gui   +10 more
wiley   +1 more source

Improved Kaplan-Meier Estimator in Survival Analysis Based on Partially Rank-Ordered Set Samples. [PDF]

open access: yesComput Math Methods Med, 2020
Nematolahi S   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy